CO5700777A2 - Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de serotonina - Google Patents
Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de serotoninaInfo
- Publication number
- CO5700777A2 CO5700777A2 CO05111852A CO05111852A CO5700777A2 CO 5700777 A2 CO5700777 A2 CO 5700777A2 CO 05111852 A CO05111852 A CO 05111852A CO 05111852 A CO05111852 A CO 05111852A CO 5700777 A2 CO5700777 A2 CO 5700777A2
- Authority
- CO
- Colombia
- Prior art keywords
- alky
- ilo
- hydrogen
- iio
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1.- Un compuesto representado por la fórmula general I en la cual R1, R2, R3, R4, R5 se seleccionan independientemente entre hidrógeno, halógeno, ciano, alqu(en/in)iIo C1-6, alqu(en/in)iIoxi C1-6, alqu(en/in)ilsulfanilo C1-6, hidroxi, hidroxi- alqu(en/in)iIo C1-6, halo- alqu(en/in)ilo C1-6, halo- alqu(en/in)iloxi C1-6, o NRxRy en donde Rx y Ry se seleccionan independientemente entre hidrógeno, alqu(en/in)iIo C1-6, cicloalqu(en)iIo C3-8, cicloalqu(en)ilo C3-8-alqu(en/in)iIo-C1-6, o NRzRw- alqu(en/in)iIo-C1-6, en donde Rz y Rw se seleccionan independientemente entre hidrógeno, alqu(en/in)ilo-C1-6, cicloalqu(en)iIo-C3-8, o cicloalqu(en)ilo-C3-8alqu(en/in)ilo-C1-6; o Rx y Ry junto con el nitrógeno al cual están unidos forman un anillo de 3-7 miembros el cual opcionalmente contiene un heteroátomo adicional; o R2 y R3 juntos forman un heterociclo fusionado al anillo de fenilo seleccionado entre ; y R1, R4, R5 son según lo definido anteriormente;R6, R7, R8, R9 se seleccionan independientemente entre hidrógeno, halógeno, alqu(en/in)ilo-C1-6, alqu(en/in)iloxiC1-6, alqu(en/in)ilsulfanilo-C1-6, hidroxi, hidroxi-alqu(en/in)ilo-C1-6, halo-alqu(en/in)iIo-C1-6, halo-alqu(en/in)iloxi-C1-6, o NRxRy en donde Rx y Ry se seleccionan independientemente entre hidrógeno, alqu(en/in)iIo-C1-6, cicloalqu(en)ilo-C3-8, cicloalqu(en)ilo-C3-8-alqu(en/in)ilo-C1-6, o NRzRw-alqu( en/in )iIoC1-6, en donde Rz y Rw se seleccionan independientemente entre hidrógeno, alqu(en/in)ilo C1-6, cicloalqu(en)iIo C3-8, o cicloalqu(en)ilo C3-8- alqu(en/in)ilo C1-6; o Rx y Ry junto con el nitrógeno al cual están unidos forman un anillo de 3-7 miembros el cual opcionalmente contiene un heteroátomo adicional;siempre que al menos uno de R1, R2, R3, R4, R5, R6, R7, R8 y R9 sea diferente de hidrógeno; también siempre y cuando R3 es metilo o metoxi, entonces al menos uno de R1, R2, R3, R4, R5, R6, R7, R8 y R9 es diferente de hidrógeno; o una sal del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46026603P | 2003-04-04 | 2003-04-04 | |
DKPA200300518 | 2003-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5700777A2 true CO5700777A2 (es) | 2006-11-30 |
Family
ID=35432910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO05111852A CO5700777A2 (es) | 2003-04-04 | 2005-11-02 | Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de serotonina |
Country Status (28)
Country | Link |
---|---|
US (1) | US20070173522A1 (es) |
EP (1) | EP1613594B1 (es) |
JP (1) | JP2006522029A (es) |
KR (1) | KR20060021825A (es) |
CN (1) | CN100384822C (es) |
AR (1) | AR043964A1 (es) |
AT (1) | ATE390413T1 (es) |
AU (1) | AU2004226319A1 (es) |
BR (1) | BRPI0408453A (es) |
CA (1) | CA2521172A1 (es) |
CL (1) | CL2004000730A1 (es) |
CO (1) | CO5700777A2 (es) |
DE (1) | DE602004012724T2 (es) |
DK (1) | DK1613594T3 (es) |
EA (1) | EA009282B1 (es) |
ES (1) | ES2301979T3 (es) |
HK (1) | HK1090051A1 (es) |
HR (1) | HRP20080243T3 (es) |
IS (1) | IS8007A (es) |
MX (1) | MXPA05010678A (es) |
NO (1) | NO20055205L (es) |
NZ (1) | NZ541944A (es) |
PL (1) | PL1613594T3 (es) |
PT (1) | PT1613594E (es) |
SI (1) | SI1613594T1 (es) |
UA (1) | UA81300C2 (es) |
WO (1) | WO2004087662A1 (es) |
ZA (1) | ZA200507182B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1626720T1 (sl) | 2003-04-04 | 2008-12-31 | Lundbeck & Co As H | Derivati 4-(2-fenilsulfanil-fenil)-piperidina kotzaviralci ponovnega vnosa serotonina |
EP2400300A1 (en) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Method of screening preventives/remedies for stress urinary incontinence |
WO2007132841A1 (ja) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物およびその用途 |
WO2009063992A1 (ja) | 2007-11-15 | 2009-05-22 | Takeda Pharmaceutical Company Limited | 縮合ピリジン誘導体およびその用途 |
UA98698C2 (en) * | 2008-03-03 | 2012-06-11 | Х. Луннбек А/С | Phenylsulfanylphenyl-piperidines and process for the preparation thereof |
JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
EP2930171A1 (en) * | 2014-04-07 | 2015-10-14 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2,4-dimethylphenyl)(2-iodophenyl)sulfane intermediate |
CN105294554B (zh) * | 2015-11-18 | 2017-11-07 | 乳源瑶族自治县大众药品贸易有限公司 | 苯基哌嗪衍生物及其使用方法和用途 |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803143A (en) * | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
US4018830A (en) * | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
US4055665A (en) * | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
US4066654A (en) * | 1975-04-16 | 1978-01-03 | G. D. Searle & Co. | 1-triarylalkyl-4-phenyl-4-piperidine carboxylic acids and derivatives |
US4056632A (en) * | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
US4241071A (en) * | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
DE2802306A1 (de) * | 1977-01-27 | 1978-08-10 | Hoechst Ag | Azacycloalkane, azacycloalkene und ihre derivate |
US4198419A (en) * | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenylthiophenylpiperidines |
US4198417A (en) * | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
GB8912971D0 (en) * | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
IL149105A0 (en) * | 1999-10-13 | 2002-11-10 | Pfizer Prodcts Inc | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
US6410736B1 (en) * | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
EP1246816B1 (en) * | 1999-12-30 | 2004-03-17 | H. Lundbeck A/S | Substituted phenyl-piperazine derivatives, their preparation and use |
US6436938B1 (en) * | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
US20020107244A1 (en) * | 2001-02-02 | 2002-08-08 | Howard Harry R. | Combination treatment for depression |
UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
-
2004
- 2004-02-04 UA UAA200508779A patent/UA81300C2/uk unknown
- 2004-04-02 EP EP04725299A patent/EP1613594B1/en not_active Expired - Lifetime
- 2004-04-02 DE DE602004012724T patent/DE602004012724T2/de not_active Expired - Fee Related
- 2004-04-02 BR BRPI0408453-5A patent/BRPI0408453A/pt not_active IP Right Cessation
- 2004-04-02 ES ES04725299T patent/ES2301979T3/es not_active Expired - Lifetime
- 2004-04-02 PT PT04725299T patent/PT1613594E/pt unknown
- 2004-04-02 DK DK04725299T patent/DK1613594T3/da active
- 2004-04-02 AR ARP040101130A patent/AR043964A1/es not_active Application Discontinuation
- 2004-04-02 SI SI200430727T patent/SI1613594T1/sl unknown
- 2004-04-02 KR KR1020057018870A patent/KR20060021825A/ko not_active Application Discontinuation
- 2004-04-02 WO PCT/DK2004/000243 patent/WO2004087662A1/en active IP Right Grant
- 2004-04-02 CN CNB2004800094713A patent/CN100384822C/zh not_active Expired - Fee Related
- 2004-04-02 NZ NZ541944A patent/NZ541944A/en unknown
- 2004-04-02 AU AU2004226319A patent/AU2004226319A1/en not_active Abandoned
- 2004-04-02 JP JP2006504348A patent/JP2006522029A/ja active Pending
- 2004-04-02 PL PL04725299T patent/PL1613594T3/pl unknown
- 2004-04-02 MX MXPA05010678A patent/MXPA05010678A/es active IP Right Grant
- 2004-04-02 ZA ZA200507182A patent/ZA200507182B/en unknown
- 2004-04-02 EA EA200501579A patent/EA009282B1/ru not_active IP Right Cessation
- 2004-04-02 CA CA002521172A patent/CA2521172A1/en not_active Abandoned
- 2004-04-02 US US10/551,869 patent/US20070173522A1/en not_active Abandoned
- 2004-04-02 CL CL200400730A patent/CL2004000730A1/es unknown
- 2004-04-02 AT AT04725299T patent/ATE390413T1/de not_active IP Right Cessation
-
2005
- 2005-08-29 IS IS8007A patent/IS8007A/is unknown
- 2005-11-02 CO CO05111852A patent/CO5700777A2/es unknown
- 2005-11-04 NO NO20055205A patent/NO20055205L/no unknown
-
2006
- 2006-09-26 HK HK06110721A patent/HK1090051A1/xx not_active IP Right Cessation
-
2008
- 2008-06-03 HR HR20080243T patent/HRP20080243T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CL2004000730A1 (es) | 2005-02-18 |
HK1090051A1 (en) | 2006-12-15 |
BRPI0408453A (pt) | 2006-04-04 |
PL1613594T3 (pl) | 2008-09-30 |
MXPA05010678A (es) | 2005-12-12 |
UA81300C2 (en) | 2007-12-25 |
CN100384822C (zh) | 2008-04-30 |
WO2004087662A1 (en) | 2004-10-14 |
ATE390413T1 (de) | 2008-04-15 |
US20070173522A1 (en) | 2007-07-26 |
DE602004012724T2 (de) | 2009-04-09 |
DK1613594T3 (da) | 2008-07-14 |
PT1613594E (pt) | 2008-07-01 |
DE602004012724D1 (de) | 2008-05-08 |
HRP20080243T3 (en) | 2009-04-30 |
JP2006522029A (ja) | 2006-09-28 |
ES2301979T3 (es) | 2008-07-01 |
AR043964A1 (es) | 2005-08-17 |
EA009282B1 (ru) | 2007-12-28 |
CN1777585A (zh) | 2006-05-24 |
NZ541944A (en) | 2008-05-30 |
IS8007A (is) | 2005-08-29 |
NO20055205L (no) | 2005-11-04 |
SI1613594T1 (sl) | 2008-08-31 |
ZA200507182B (en) | 2006-12-27 |
EP1613594B1 (en) | 2008-03-26 |
CA2521172A1 (en) | 2004-10-14 |
EP1613594A1 (en) | 2006-01-11 |
KR20060021825A (ko) | 2006-03-08 |
AU2004226319A1 (en) | 2004-10-14 |
EA200501579A1 (ru) | 2006-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5700777A2 (es) | Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de serotonina | |
ES2613538T3 (es) | Derivados de arilamida como bloqueadores de TTX-S | |
ES2590504T3 (es) | N-ciclilamidas como nematicidas | |
ECSP11010912A (es) | Compuestos de pirrol | |
ES2669189T3 (es) | Compuestos de carbazol útiles como inhibidores del bromodominio | |
NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
AR049784A1 (es) | Derivados sustituidos de morfolina y tiomorfolina | |
CO6150164A2 (es) | Derivados de 2-metilmorfolina pirido-,pirazo-ypirimido-pirimidina como inhibidores de mtor | |
CO5611147A2 (es) | Derivados de nicotinamida utiles como inhibidores p38 | |
CO6321244A2 (es) | Pirrolopiridinas como inhibidores de cinasa | |
CO5611139A2 (es) | Pirimidinas aril sustituidas y el uso de las mismas | |
ES2722409T3 (es) | Moduladores de ROR gamma (RORy) | |
AR112338A2 (es) | Arilciclohexiléteres de dihidro-tetraazabenzoazuleno | |
EA200970493A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
ES2600636T3 (es) | Spiro-[1,3]-oxazinas y spiro-[1,4]-oxazepinas como inhibidores de BACE1 y/o BACE2 | |
PE20130155A1 (es) | Derivados de ariletinilo | |
CO5601027A2 (es) | Derivados de imidazol-4-il-etinil-piridina | |
CO5650235A2 (es) | Derivados de imidazol | |
AR069480A1 (es) | Derivados de 2-amino-pirimidina | |
AR084913A1 (es) | Derivados de aril-benzocicloalquil-amida | |
CO6241119A2 (es) | Compuestos de pirido 2,3-d pirimidina-7-ona como inhibidores de pi3k-alfa para el tratamiento del cancer | |
CO5700763A2 (es) | Derivados de 1-bencil-5-piperazin-1-il-3,4-dihidro-1h-quinazolin-2-ona y el respexctivo 1h-benzo (1,2,6)tiadiazin-2,2-dioxido y derivados de 1,4-dihidro-benzo (d) (1,3) oxazin-2-ona como moduladores del receptor 5-hidroxitriptamina (5-ht) para el tra | |
EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
MX2011011281A (es) | Compuesto de carbinol que tiene un enlazante heterociclico. | |
ES2650372T3 (es) | Compuestos tricíclicos como inhibidores de CFTR |